Ong, S Tiong <br/><br/>
Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia.  [electronic resource] 

 -  Nature medicine  Oct 2014 
 - 1090-1 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1546-170X 
<br/><br/><label>Standard No.: </label>10.1038/nm.3652  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--genetics<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics<br/>Lung Neoplasms--genetics<br/>Male<br/>Membrane Proteins--genetics<br/>Polymorphism, Genetic--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins--genetics<br/>Sequence Deletion--genetics